Described herein are methods for treating inflammatory disorders. The methods comprise administering to a subject in need thereof a therapeutically effective amount of a synthetically modified fullerene.

Claims

3 · 1 independent · depth 2

3 granted claims

›1.independentA compound selected from the group consisting of C70-tetraglycolic acid, C70-tetrainositol, C70-TEG acid, and phenylpropionic acid-triazole-mixed malo…+2

Classifications

7 codes

IPC · International Patent Classification

Section A — Human necessities

A61K31/41
A61K31/235

Section C — Chemistry; metallurgy

C07C67/48
C07D403/00

USPC · US Patent Classification

514/359514/532548/255

Claim changes

Soon

Coming soonHow the claims changed between publication and grant

See which claims were amended, added or cancelled during examination, with every added and removed word marked.

AmendedAddedCancelledUnchanged

The published claims of this patent are not paired with the granted ones in what we hold.

File wrapper

Pendency

4.6 y

1,694 days filing → grant

Office actions

after a restriction

Responses

1 RCE

Interviews

examiner interview summaries

Examiner

Shengjun Wang

art unit 1627 · TC 1600

Law firm

Law firm · Log in to unlock

Citations: 11 back · 0 forward

See the full prosecution history — every USPTO and applicant action on this file, in order.

Term & fees

See the term timeline — pendency span, in-force span, the maintenance fees paid and both computed expiry dates.

Priority chain

2 priority documents

Priority

3 Mar 2008

earliest claimed

›Priority documents — 2

Type	Document	Date
provisional	US 61033309	3 Mar 2008
related publication	US 20110028522 A1	3 Feb 2011

Validity challenges

See the validity challenges on record — reexaminations, IPRs and PGRs, with their institution decisions and outcomes.

Citations

See every patent this one cites and every patent that cites it back — publication, assignee, and how each one was found.